A. Marilyn Leitch

9.0k total citations · 4 hit papers
32 papers, 5.5k citations indexed

About

A. Marilyn Leitch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Marilyn Leitch has authored 32 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 17 papers in Oncology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in A. Marilyn Leitch's work include Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (14 papers) and Breast Implant and Reconstruction (7 papers). A. Marilyn Leitch is often cited by papers focused on Breast Cancer Treatment Studies (23 papers), Breast Lesions and Carcinomas (14 papers) and Breast Implant and Reconstruction (7 papers). A. Marilyn Leitch collaborates with scholars based in United States, Switzerland and India. A. Marilyn Leitch's co-authors include Kelly K. Hunt, Linda McCall, Armando E. Giuliano, Peter Blumencranz, Peter D. Beitsch, Pat W. Whitworth, Karla V. Ballman, Sukamal Saha, Monica Morrow and Douglas S. Reintgen and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Oncology.

In The Last Decade

A. Marilyn Leitch

31 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

2017 1.1k citations Armando E. Giuliano, Karla V. Ballman et al. JAMA profile →
Oxidative stress inhibits distant metastasis by human melanoma cells

2015 929 citations Elena Piskounova, Michalis Agathocleous et al. Nature profile →
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

2010 879 citations Armando E. Giuliano, Linda McCall et al. Annals of Surgery profile →
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

2007 660 citations Linda McCall, Peter D. Beitsch et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Marilyn Leitch United States	22	4.0k	2.5k	2.1k	2.1k	902	32	5.5k
R. Douglas Macmillan United Kingdom	38	2.1k 0.5×	1.1k 0.4×	1.1k 0.5×	2.4k 1.2×	1.0k 1.1×	75	4.8k
Janet K. Horton United States	28	2.2k 0.6×	1.2k 0.5×	1.3k 0.6×	1.1k 0.5×	480 0.5×	87	3.9k
Jennifer R. Bellon United States	35	4.2k 1.0×	1.9k 0.8×	1.0k 0.5×	3.5k 1.7×	763 0.8×	164	6.8k
Caroline Speers Canada	35	3.3k 0.8×	1.2k 0.5×	992 0.5×	4.0k 1.9×	843 0.9×	140	6.3k
Cornelia Liedtke Germany	29	4.4k 1.1×	1.7k 0.7×	889 0.4×	4.3k 2.1×	2.6k 2.8×	95	7.6k
J. Michael Dixon United Kingdom	33	3.2k 0.8×	1.6k 0.7×	1.2k 0.6×	2.4k 1.2×	914 1.0×	82	5.0k
Joseph Ragaz Canada	20	3.6k 0.9×	1.6k 0.7×	1.1k 0.5×	2.8k 1.4×	1.1k 1.2×	69	5.6k
Carolyn Taylor United Kingdom	18	5.3k 1.3×	1.7k 0.7×	1.2k 0.6×	2.6k 1.3×	581 0.6×	32	7.9k
Dilip D. Giri United States	37	2.4k 0.6×	1.1k 0.4×	617 0.3×	2.9k 1.4×	3.0k 3.3×	94	7.0k
Ja Seung Koo South Korea	43	2.8k 0.7×	896 0.4×	565 0.3×	2.4k 1.1×	2.7k 3.0×	231	6.3k

Countries citing papers authored by A. Marilyn Leitch

Since Specialization

Citations

This map shows the geographic impact of A. Marilyn Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Marilyn Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Marilyn Leitch more than expected).

Fields of papers citing papers by A. Marilyn Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Marilyn Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Marilyn Leitch. The network helps show where A. Marilyn Leitch may publish in the future.

Co-authorship network of co-authors of A. Marilyn Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of A. Marilyn Leitch. A scholar is included among the top collaborators of A. Marilyn Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Marilyn Leitch. A. Marilyn Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lesurf, Robert, Obi L. Griffith, Malachi Griffith, et al.. (2017). Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial. Annals of Oncology. 28(5). 1070–1077. 47 indexed citations

Sanders, Mary Ann, et al.. (2017). Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases. Clinical Breast Cancer. 18(4). 298–304. 25 indexed citations

Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2017). Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis. JAMA. 318(10). 918–918. 1080 indexed citations breakdown →

Suman, VJ, et al.. (2016). Abstract P1-14-02: Disease-free (DFS) and overall survival (OS) data from ACOSOG Z1041 (Alliance) a randomized neoadjuvant trial comparing FEC followed by paclitaxel plus trastuzumab (FEC → P+T) with paclitaxel plus trastuzumab followed by FEC plus trastuzumab (P+T → FEC+T) in HER2-positive operable breast cancer. Cancer Research. 76(4_Supplement). P1–14.

Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2016). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 264(3). 413–420. 336 indexed citations

Huth, James F., et al.. (2015). Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple‐negative breast cancer. Cancer Medicine. 4(4). 500–506. 13 indexed citations

Sanati, Souzan, Vera J. Suman, Rodrigo Gonçalves, et al.. (2015). Abstract P4-11-13: Validation of the preoperative endocrine prognostic index in the ACOSOG (Alliance) Z1031 neoadjuvant aromatase inhibitor trial. Cancer Research. 75(9_Supplement). P4–11. 2 indexed citations

Piskounova, Elena, Michalis Agathocleous, Malea M. Murphy, et al.. (2015). Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 527(7577). 186–191. 929 indexed citations breakdown →

Buzdar, Aman U., Vera J. Suman, Funda Meric‐Bernstam, et al.. (2013). Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial. The Lancet Oncology. 14(13). 1317–1325. 120 indexed citations

10.

Suman, VJ, EA Mittendorf, Bret Taback, et al.. (2012). Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial. Cancer Research. 72(24_Supplement). S2–1. 33 indexed citations

11.

Giuliano, Armando E., Debra Hawes, Karla V. Ballman, et al.. (2011). Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer. JAMA. 306(4). 385–385. 178 indexed citations

12.

Le‐Petross, Huong T., Vera J. Suman, Bruce G. Haffty, et al.. (2010). A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071.. Journal of Clinical Oncology. 28(15_suppl). TPS118–TPS118. 1 indexed citations

13.

Cote, Rick, A. E. Giuliano, Debra Hawes, et al.. (2010). ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer.. Journal of Clinical Oncology. 28(18_suppl). CRA504–CRA504. 34 indexed citations

14.

Giuliano, Armando E., Linda McCall, Peter D. Beitsch, et al.. (2010). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 252(3). 426–433. 879 indexed citations breakdown →

15.

Xie, Xian‐Jin, Jingsheng Yan, David Euhus, et al.. (2010). Impact of Routine Cavity Shave Margins on Breast Cancer Re-excision Rates. Annals of Surgical Oncology. 18(5). 1349–1355. 67 indexed citations

16.

Peng, Yan, et al.. (2008). False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular Inclusions. American Journal of Clinical Pathology. 130(1). 21–27. 16 indexed citations

17.

Sakaguchi, Masahiro, Arvind K. Virmani, George N. Peters, et al.. (2003). Clinical Relevance of Reverse Transcriptase-Polymerase Chain Reaction for the Detection of Axillary Lymph Node Metastases in Breast Cancer. Annals of Surgical Oncology. 10(2). 117–125. 27 indexed citations

18.

Euhus, David, Leslie Cler, Narayan Shivapurkar, et al.. (2002). Loss of Heterozygosity in Benign Breast Epithelium in Relation to Breast Cancer Risk. JNCI Journal of the National Cancer Institute. 94(11). 858–860. 32 indexed citations

19.

Gazdar, Adi F., Arvind K. Virmani, Lauren Gollahon, et al.. (1998). Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. International Journal of Cancer. 78(6). 766–774. 242 indexed citations

20.

Leitch, A. Marilyn, et al.. (1994). Breast cancer in a county hospital population: Impact of breast screening on stage of presentation. Annals of Surgical Oncology. 1(6). 516–520. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact